Trials / Completed
CompletedNCT02237989
Effects Of Native Collagen Type 2 Treatment
Effects Of Native Collagen Type 2 Treatment In Knee Osteoarthritis : A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Eskisehir Osmangazi University · Academic / Other
- Sex
- All
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to evaluate symptomatic efficacy of native collagen type 2 on joint pain and function and its effects on urinary biological markers related to cartilage degeneration in patients with knee osteoarthritis.
Detailed description
39 patients diagnosed with knee osteoarthritis were separated into two groups. The 1st group includes 19 patients given 1500mg/day paracetamol, the 2nd group consists of 20 patients given 1500mg/day paracetamol and 10mg/day native collagen type 2 for three months.Pretreatment and posttreatment Visual Analog Scale, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), 20-m walking time and Short Form-36 (SF-36), Coll2-1, Coll2-1NO2 and Fibulin-3 levels in urine were compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | paracetamol | 1500 mg |
| DRUG | paracetamol+native collagen type 2 | paracetamol (1500 mg) + native collagen type 2 (10mg) |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2014-09-12
- Last updated
- 2020-09-18
- Results posted
- 2020-09-18
Source: ClinicalTrials.gov record NCT02237989. Inclusion in this directory is not an endorsement.